These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4443332)

  • 1. Effect of glucose loading on serum glycoproteins.
    Ghai RD; Pai ML; Shah CP; Srinvasan S
    J Assoc Physicians India; 1974 Aug; 22(8):597-600. PubMed ID: 4443332
    [No Abstract]   [Full Text] [Related]  

  • 2. [Research on the euglycemic effect of a new, delayed-action phenformin in florid diabetic patients during oral glucose tolerance test].
    Vailati G; Cuttica F; Montini M; Rebba A; Pagani G
    Clin Ter; 1974 Jan; 68(2):149-70. PubMed ID: 4596250
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of phenethylbiguanide on the behavior of blood insulin in obesity and aketosic fat diabetes].
    Fratino P; Maggi G; Rodari T
    Clin Ter; 1969 Jun; 49(5):449-59. PubMed ID: 5386745
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of phenformin on peripheral glucose utilization and insulin action in obesity and diabetes mellitus.
    Butterfield WJ
    Ann N Y Acad Sci; 1968 Mar; 148(3):724-33. PubMed ID: 5242146
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of 1-butyl-biguanidine on serum glycoproteins in patients with adult onset diabetes].
    Knapik Z; Kowal-Gierczak B; Paczyńska D
    Pol Tyg Lek; 1971 Jul; 26(6):211-3. PubMed ID: 5573313
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum prolactin in obese subjects with glucose intolerance before and after treatment with phenformin].
    Pata P; Smedile G; Morabito S; Mancuso TR; Arcoraci A
    Boll Soc Ital Biol Sper; 1981 Mar; 57(5):522-5. PubMed ID: 7020721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The UGDP--tolbutamide and mortality.
    Knowles HC
    Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432
    [No Abstract]   [Full Text] [Related]  

  • 9. Comments on the UGDP study.
    Schöffling K
    Horm Metab Res; 1974; Suppl 4():188-91. PubMed ID: 4608018
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of phenphormin on blood fibrinolysis in diabetes mellitus.
    Fiaschi E; Barbui T; Previato G; Di Luzio V; Guarnieri GF; Todesco S
    Arzneimittelforschung; 1969 Apr; 19(4):638-40. PubMed ID: 5819165
    [No Abstract]   [Full Text] [Related]  

  • 11. Assimilation of glucose in diabetes mellitus.
    Tripathy AM; Das M
    J Assoc Physicians India; 1969 May; 17(5):339-43. PubMed ID: 5350178
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood insulin, glucagon and glucose levels in latent diabetes mellitus determined during glucose tolerance test (effect of phenformin)].
    Tikhonova NE
    Ter Arkh; 1982; 54(10):12-6. PubMed ID: 6758166
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the clinical use of biguanides].
    Haese E
    Arzneimittelforschung; 1969 Apr; 19(4):633-8. PubMed ID: 5819164
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of tolbutamide on serum glucose level, specific activity of glucose and glucose oxidation in severe diabetes.
    Adlung J; Koch CD
    Int J Clin Pharmacol; 1974 Sep; 10(2):128-35. PubMed ID: 4448554
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of a new oral drug in the treatment of diabetes mellitus].
    Lubetzki J
    Diabete; 1971; 19(3):185-90. PubMed ID: 5002990
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of propranolol and chlorophenoxybutyric acid (CPJB) on the dynamics of free fatty acids and blood sugar].
    Haller H; Julius U; Leonhardt W; Hanefeld M
    Dtsch Z Verdau Stoffwechselkr; 1972; 32(5):391-9. PubMed ID: 4667787
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of two methods for the elimination of plasma glucose in the determination of glycated plasma proteins.
    Juretić D; Lipovac K; Flogel M; Borcić O; Cepelak I; Zanić T
    Z Med Lab Diagn; 1987; 28(6):316-9. PubMed ID: 3424913
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in ketonemia in patients with diabetes mellitus of the insulin deficiency type after glucose loading].
    Nocheva MG
    Ter Arkh; 1968 Mar; 40(3):34-8. PubMed ID: 4970178
    [No Abstract]   [Full Text] [Related]  

  • 19. [Impairment of intestinal glucose absorption by biguanide derivatives].
    Czyzyk A
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():636-43. PubMed ID: 5371309
    [No Abstract]   [Full Text] [Related]  

  • 20. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.